General
Preferred name
CETHROMYCIN
Synonyms
P&D ID
PD131769
CAS
205110-48-1
Tags
drug candidate
natural product
Drug indication
Bacterial infection
Pneumonia
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Cethromycin is an orally bioavailable ketolide antibacterial that is structurally related to . It was developed by Abbott Laboratories for potential to treat respiratory infections, including community acquired pneumonia (CAP) and for the prevention of post-exposure inhalational anthrax .
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
13
Molecular Weight
765.42
Hydrogen Bond Acceptors
12
Hydrogen Bond Donors
2
Rotatable Bonds
8
Ring Count
5
Aromatic Ring Count
2
cLogP
5.11
TPSA
162.82
Fraction CSP3
0.64
Chiral centers
13.0
Largest ring
14.0
QED
0.27
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
